Related Experiment Video
Updated: May 28, 2025
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
9.9K
[Non-Hodgkin's lymphomas: a short overview]
1Medizinische Klinik und Poliklinik III, LMU Klinikum, Marchioninistraße 15, 81377, München, Deutschland.
Innere Medizin (Heidelberg, Germany)
|February 11, 2025
Summary
Non-Hodgkin's lymphomas are diverse immune system cancers. New targeted therapies, including CAR T-cell therapy, are improving treatment outcomes beyond traditional chemotherapy.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of cancers originating from immune system's lymphatic cells.
- NHL are clinically categorized into indolent and aggressive subtypes, impacting prognosis and treatment strategies.
Purpose of the Study:
- To review the current landscape of Non-Hodgkin's lymphoma classification and treatment.
- To highlight recent advancements in therapeutic options for NHL.
Main Methods:
- Literature review of Non-Hodgkin's lymphoma classification.
- Analysis of treatment goals for indolent versus aggressive lymphoma.
- Overview of novel therapeutic modalities including targeted and cellular therapies.
Main Results:
- NHL classification into indolent and aggressive forms guides therapeutic approaches and prognosis.
- Aggressive lymphomas aim for complete remission via intensive treatment.
- Indolent lymphomas focus on disease control rather than cure.
Conclusions:
- Recent therapeutic developments, including targeted therapies and chimeric antigen receptor (CAR) T-cells, have significantly improved outcomes for Non-Hodgkin's lymphoma patients.
- Novel treatment strategies offer new hope for managing both indolent and aggressive lymphoma subtypes.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
832
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
832
01:16Primary Lymphoid Organs
1.3K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
1.3K
01:27Disorders of Leukocytes
838
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
838
01:24B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
01:23Cells of the Adaptive Immune Response
940
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
940
01:18Lymphoid Cells and Tissues
952
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
952